REQUEST A DEMO
Total
USD $0.00
Search more companies

Neopharma Sas (Colombia)

Main Activities: Pharmacies and Drug Stores
Full name: Neopharma Sas Profile Updated: May 12, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Neopharma Sas is based in Colombia, with the head office in Bogota D.C.. It operates in the Pharmacies and Drug Stores industry. It was first established on May 10, 2007. Neopharma Sas currently employs 16 (2026) people. In 2025, the company reported a net sales revenue increase of 37.49%. During that time, Neopharma Sas’s total assets grew by 33.77%. The enterprise’s net profit margin decreased by 0.24% in 2025.

Headquarters
Carrera 72 J Bis 36 54 Sur
Bogota D.C.; Bogota D.C; Postal Code: 0402

Contact Details: Purchase the Neopharma Sas report to view the information.

Basic Information
Total Employees:
Purchase the Neopharma Sas report to view the information.
Financial Auditors:
Purchase the Neopharma Sas report to view the information.
Incorporation Date:
May 10, 2007
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Neopharma Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
37.49%
Total Operating Revenue
37.49%
Operating Profit
9.42%
Net Profit/Loss for the Period
27.22%
Total Assets
33.77%
Total Equity
14.59%
Operating Profit Margin
-3.2%
Net Profit Margin
-0.24%
Return on Equity (ROE)
1.28%
Quick Ratio
-1.6%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?